System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Pavan Bhargava, MD is an expert in Neurology at Johns Hopkins School of Medicine (United States). As of October 2026, ScienceLeadR ranks Pavan Bhargava in the top 1% of experts worldwide for Multiple Sclerosis and Autoimmune Diseases. Pavan Bhargava has authored 126 publications, the most recent in 2026, and is an investigator in 7 clinical trials. SLR score: 744 (community average: 125). How the SLR is computed.

LeadR Profile

Pavan Bhargava, MD Johns Hopkins School of Medicine United States
744 ScienceLeadR Reputation 744

Unlock

Register Login
Network Map

Neurology

Subspecialties: Immunology - Urology - Psychiatry

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2013 - 2026
Source: PubMed

Johns Hopkins School of Medicine

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 126

Citations

Citations: 3 639 1st author: 36 Last author: 31 Unique author: 6

Main journals

Neurology 30
Mult Scler 13
Ann Clin Transl Neurol 6
Brain 6
medRxiv 6

Best Journals

Science 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Investigation of Complement Activation and Cytokine Signatures in AQP4+ NMOSD, MOGAD, and MS.
PMID 42908053 — cytokines, multiple sclerosis, neuromyelitis optica, complement system proteins, complement activation, nervous system diseases, plasma, neuroinflammatory diseases		Ann Clin Transl Neurol20260
Metabolomic Signatures of Brain Atrophy and Ibudilast Response in Progressive Multiple Sclerosis.
PMID 42282152 — white matter, sclerosis, genes, multiple sclerosis, gray matter, atrophy, brain, glycerophospholipids, biomarkers, metabolomics, work, therapeutics, tissues, steroids, sphingomyelins, plasma		medRxiv20260
Proteomic Age Acceleration in Multiple Sclerosis Precedes Symptom Onset and Associates with Severity.
PMID 42078367 — sclerosis, multiple sclerosis, muscles, aging, brain, nerve fibers, walking speed, walking, retinaldehyde		medRxiv20260
Accelerated metabolomic aging and its association with social determinants of health in multiple sclerosis.
PMID 41718456 — sclerosis, multiple sclerosis, aging, metabolomics		Mult Scler20260
OMG! A proteomic determinant of neurodegenerative resiliency.
PMID 41491993 — dementia, brain, proteomics, amyloid		Mol Neurodegener20260

Clinical Studies 7

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 3 Study Director: 1

By phase:

N/A 3
Phase 3 2
Phase 1/Phase 2 1
Phase 2 1

By status:

Completed 6
Terminated 1

By type:

Interventional 6
Observational 1

By Monocentric/Multicentric:

monocentric 4
multicentric2to4 1
multicentric5to9 0
multicentricup10 2

Main Topics

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS